Signal Explorer
10-K · 10-Q · 8-K · last 6 months · ← back to feed
Acurx Pharmaceuticals, Inc.
ACXP
Other
Corporate Organization And Standing Representation
Market Price Definition
Institutional Investment
Ipo Or Capital Raising Completion
Form S3 Shelf Registration Disclosure
Warrant Exercise Share Delivery
Ipo Net Proceeds Disclosure
Core
Lead Asset Progress
Indication Expansion
Other
Warrant Valued Black Scholes
Reverse Stock Split Effected
Ipo Or Capital Raising Completion
Committee Meeting Attendance Disclosure
Classified Board Director Election
Executive Educational Background Disclosure
Personnel Cost Decrease Disclosure
Nasdaq Minimum Bid Price Delisting Notice
Financing Activities Cash Flow Disclosure
Institutional Investment
Patent Family Portfolio Disclosure
Net Loss Reported
Cybersecurity Risk Management Program Disclosure
Audit Committee Preapproval Policy
Core
Clinical Trial Result
Other
Fast Track Designation Received
Fast Track Granted
Earnings Call Replay Details
Orphan Status Granted
Non Employee Director Compensation Disclosed
Enrollment Ahead Of Schedule
Patient Retention High
Expanded Access Program Active
Breakthrough Therapy Granted
Interim Data Positive
Core
Clinical Trial Result
Regulatory Designation Only
Lead Asset Progress
Patient Enrollment Velocity
Biotech Risk
Orphan Drug Designation
Other
Financing Activities Cash Flow Disclosure
Net Loss Reported
Personnel Cost Decrease Disclosure
Reverse Stock Split Effected
Nasdaq Minimum Bid Price Delisting Notice
Ipo Or Capital Raising Completion
Equity Plan Share Reserve Disclosure
Nyse Listing Disclosure
Cybersecurity Breach Reputational Harm Disclosure
Equity Plan Board Approval Conditional On Shareholder Vote
Administrative Efficiency
Shares Outstanding Disclosure
Stock Option Grant Disclosed
Institutional Investment
Core
Indication Expansion